Stock Traders Buy High Volume of Oscar Health Call Options (NYSE:OSCR)

Oscar Health, Inc. (NYSE:OSCR) saw some unusual options trading on Friday. Traders purchased 33,687 call options on the stock. This is an increase of approximately 55% compared to the typical volume of 21,746 call options.

Insider Activity at Oscar Health

In other news, CAO Victoria Baltrus sold 958 shares of Oscar Health stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $30,129.10. Following the completion of the sale, the chief accounting officer owned 213,631 shares in the company, valued at approximately $6,718,694.95. This trade represents a 0.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,092 shares of Oscar Health stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $285,943.40. Following the sale, the insider owned 209,004 shares of the company’s stock, valued at approximately $6,573,175.80. This trade represents a 4.17% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 4,322,257 shares of company stock valued at $126,818,346 in the last ninety days. 22.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Oscar Health

A number of institutional investors have recently made changes to their positions in the stock. Jones Financial Companies Lllp raised its holdings in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio bought a new stake in Oscar Health in the 1st quarter worth $30,000. CoreCap Advisors LLC increased its position in shares of Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after acquiring an additional 1,000 shares during the period. Quarry LP increased its position in shares of Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the period. Finally, GAMMA Investing LLC raised its stake in shares of Oscar Health by 32.9% during the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after acquiring an additional 357 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $32.70 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The stock has a market cap of $10.09 billion, a PE ratio of 23.36, a PEG ratio of 0.67 and a beta of 2.37. The company’s fifty day moving average is $30.60 and its 200 day moving average is $23.34. Oscar Health has a 52 week low of $10.69 and a 52 week high of $34.23.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The firm had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same period last year, the firm earned ($0.89) earnings per share. The company’s revenue for the quarter was up 70.4% compared to the same quarter last year. Research analysts anticipate that Oscar Health will post 1.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on OSCR shares. Wells Fargo & Company lifted their target price on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. Piper Sandler restated an “overweight” rating and set a $36.00 price objective on shares of Oscar Health in a research report on Tuesday, July 28th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Barclays lifted their price target on Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Finally, Weiss Ratings upgraded Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $26.22.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.